Table 3 The association of COVID-19 infections with the study variables in each study group
COVID-19-positive cases in the case group (N = 16) | COVID-19-positive cases in the control group (N = 16) | |||||
|---|---|---|---|---|---|---|
N (%) | Pearson’s coefficient | p value | N (%) | Pearson’s coefficient | p value | |
Underlying diseases | ||||||
Diabetes mellitus | – | 0.108 | 0.611 | 1 (6.2%) | 0.202 | 0.533 |
Cardiovascular disease | – | 1 (6.2%) | ||||
Hypertension | – | 2 (12.5%) | ||||
Asthma | – | 1 (6.2%) | ||||
Allergy | – | 1 (6.2%) | ||||
Rheumatoid arthritis | 2 (12.5%) | 1 (6.2%) | ||||
Thyroid disease | 5 (31%) | 0.032 | 0.471 | 3 (18.6%) | 0.026 | 0.588 |
Admission due to COVID-19 | 1 (6.2%) | 0.246 | < 0.001 | 0 | – | – |
H1N1 vaccination | 1 (6.2%) | 0.026 | 0.445 | 13 (81.2%) | 0.026 | 0.554 |
Travel | 1 (6.2%) | 0.006 | 1.000 | 4 (25%) | 0.803 | 0.465 |
Social distancing | 5 (31%) | 0.043 | 0.355 | 4 (25%) | 0.089 | 0.510 |
Close contact | 8 (50%) | 0.331 | < 0.001 | 6 (37.5%) | 0.244 | < 0.001 |